Zobrazeno 1 - 10
of 32
pro vyhledávání: '"S I, Makarova"'
Autor:
S. I. Makarova, D. V. Mitrofanov, E. G. Komova, I. V. Kaloshkin, A. B. Shintyapina, L. F. Kaznacheeva, V. V. Zelenskaya, Е. G. Kondyurina, О. A. Batychko, V. A. Vavilin
Publikováno v:
Сибирский научный медицинский журнал, Vol 41, Iss 3, Pp 58-63 (2021)
Atopic diseases remain one of the most common childhood diseases. At the beginning of life, atopic dermatitis (AD) occurs, and only then bronchial asthma (BA). This staged development of sensitization and transformation of clinical manifestations is
Externí odkaz:
https://doaj.org/article/38779679915e497c93a553d8af75274b
Autor:
S. I. Makarova, D. V. Mitrofanov, A. B. Shintyapina, E. G. Komova, V. V. Zelenskaya, T. V. Kartseva, E. G. Kondyurina, V. A. Vavilin
Publikováno v:
The Siberian Journal of Clinical and Experimental Medicine. 36:92-98
High prevalence of bronchial asthma among the population (about 300 million people all over the world) provides rationale for the search for candidate genes of disease. Human acidic chitinase (CHIA (AMCase)), encoded by theCHIAgene, is involved in th
Autor:
Yu. I. Ragino, V. A. Vavilin, N. F. Salakhutdinov, S. I. Makarova, E. M. Stakhneva, O. G. Safronova
Publikováno v:
Атеросклероз, Vol 6, Iss 1, Pp 5-11 (2010)
In cholesterol-fed rabbits with hypercholesterolemia it was revealed that complex of simvastatin (SV) with glycyrrhizic acid (1–4), simvaglyzin (SVG) had reduced effect on total blood cholesterol (CH) in appropriated equiponderant doses of SV 40, 6
Externí odkaz:
https://doaj.org/article/8145e16a7e1648afbb4796566d233a8f
Autor:
E. V. Vinogradova, Svetlana V. Aidagulova, O. A. Postnikova, E. G. Shchepotina, D. L. Nepomnyashchikh, S. I. Makarova, Yu. Yu. Karavaeva, V. V. Lyakhovich, V. A. Vavilin, Zh. V. Nokhrina
Publikováno v:
Bulletin of Experimental Biology and Medicine. 152:633-636
Patients with infectious viral or toxic cirrhosis of the liver participated in complex clinical pathomorphological and molecular-genetic study aimed at the search for markers of predisposition to accelerated liver fibrosis, in which the xenobiotic bi
Autor:
G. A. Tolstikov, Nariman F. Salakhutdinov, V. A. Vavilin, E. M. Stakhneva, O. G. Safronova, S. I. Makarova, V. V. Lyakhovich, Yu. P. Nikitin, Yu. I. Ragino
Publikováno v:
Bulletin of Experimental Biology and Medicine. 146:206-209
Simvaglyzin, a complex compound of simvastatin and glycyrrhizic acid, administered to rabbits with experimental hypercholesterolemiain in doses equivalent to 66.6 and 40 microg/kg simvastatin exhibited antioxidant capacity (decreased the content of l
Autor:
S. I. Makarova
Publikováno v:
Current Drug Metabolism. 9:538-545
There are a lot of pharmaceutical substances nowadays on the market. More than 1000 drugs have been implicated in causing liver diseases in more than one occasion. The liver is the most massive and important internal organ of human body. The morpholo
Publikováno v:
Bulletin of Experimental Biology and Medicine. 143:83-86
The incidence of 5 polymorphisms of N-acetyltransferase-2 gene was evaluated in patients with lung cancer. A803G polymorphism is a factor of lung cancer resistance in tobacco smoking Caucasians in Novosibirsk. Opposite effects of NAT2 gene polymorphi
Publikováno v:
Scopus-Elsevier
Restriction analysis of the NAT2 gene was carried out in inhabitants of Novosibirsk. Polymorphism of this gene for nine known point mutations was studied in a sample of Novosibirsk residents consisting of 109 healthy Caucasians. The frequencies of th
Publikováno v:
Russian Journal of Genetics. 38:439-445
The frequencies of theCYP1A1valine allele, homozygous deletions of GSTM1 and GSTT1, and two point mutations of the NAT2 gene, NAT2: S1(C481 → T) and S2 (G590 → A), were compared in healthy children and children having bronchial asthma. The S1 mut
Autor:
Yu. Yu. Karavaeva, E. V. Vinogradova, V. V. Lyakhovich, Zh. V. Nokhrina, D. L. Nepomnyashchikh, S. I. Makarova, V. A. Vavilin, E. G. Shchepotina, A. V. Kudryashov
Publikováno v:
Bulletin of experimental biology and medicine. 156(2)
1297C/T polymorphism of CYP4F2 gene was studied in 108 patients with chronic liver diseases. No significant correlation with predisposition to rapid liver cirrhosis was revealed without consideration for cirrhosis etiology (OR = 0.93, 95% CI = 0.28-2